Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

601 – Comprehensive Study of CSF Fluid β2-Microglobulin, a Marker of CNS Immune Activation in HIV

Background HIV-1 invades the central nervous system (CNS) during acute infection and thereafter persists in the CNS. This leads to chronic intrathecal immune activation which can be measured by various biomarkers in cerebrospinal fluid (CSF). β2-microglobulin (β2M) is a marker of cellular immune activation that has previously been studied in CSF in people with HIV…

610 – Cerebrospinal Fluid Proteomic Patterns Vary With Neurobehavioral Characteristics

Background Current classification methods of neurobehavioral (NB) disorders in people with HIV (PWH) do not reflect their underlying biology well. We compared cerebrospinal fluid (CSF) proteomics between current classification methods and novel, multidimensional NB phenotypes (NBPs) to determine their biological associations.  Methods We assayed CSF from 286 virally suppressed participants with the Olink Target-96 Inflammation…

926 – Cognitive Trajectories 1 Year Before and After COVID-19 in an Early-Treated HIV Cohort

Background There is accumulating evidence that SARS-CoV-2 infection may have lasting effects on cognition in a subset of individuals. However, there is scarce data on the impact of COVID-19 on cognitive performance in people with HIV (PWH), who may experience cognitive impairment despite viral suppression by antiretroviral therapy (ART). We examined the trajectory of cognitive parameters 1…

633 – Plasma Neopterin as a Potential Biomarker for Neurocognitive Impairment in Aging People With HIV

Background Neopterin, a biomarker of immune activation, has been widely studied in cerebrospinal fluid as a correlate of neuroinflammation and neurocognitive impairment (NCI) in people with HIV (PWH). Recent evidence suggests that plasma neopterin could be useful in identifying PWH at risk of developing NCI. This study explores neopterin as a potential plasma biomarker for NCI using…

636 – Association of Delayed HIV Diagnosis or ART Initiation With Risk of Age-Associated Dementia

Background Recent studies have reported that older adults with HIV infection are at elevated risk of age-associated dementia despite antiretroviral therapy (ART). We investigated the hypothesis that delayed HIV diagnosis or initiation of ART could contribute to greater risk of developing dementia later in life.  Methods We conducted a retrospective cohort study of people with…

612 – Epigenetic Age Advancement Predicts Cognitive Performance in Older People With HIV

Background Epigenetic studies have shown an accelerated epigenetic age phenotype in people with HIV (PWH). Accelerated epigenetic age has been linked to various disease outcomes including cognitive dysfunction. However, whether epigenetic age estimates predict cognitive measures in PWH remains understudied. Methods PWH age 50 and older were recruited at an urban academic medical. Participants provided…

638 – Systemic Immune-Inflammation Index Links to Slower Psychomotor Speed in Older People With HIV

Background Persistent inflammation and immune activation are hallmark features of HIV disease, and associated with long-term brain health disorders, such as neurocognitive impairment even in treated people with HIV (PWH). As PWH age, the interactions between aging, inflammation, and brain health are important to understand. The Systemic Immune-Inflammation Index (SII) has prognostic value as an indicator…

592 – Plasma Inflammation Is Associated With Brain Cellularity in Diffusion-Based Spectral Imaging in HIV

Background Elevated levels of inflammation and neurodegeneration in the brain and periphery are associated with worse brain health outcomes in persons without HIV (PWoH). People with HIV (PWH) may have greater peripheral inflammation and neurodegeneration that may cause elevated brain inflammation and white matter changes. Brain inflammation can be measured using diffusion-based spectral imaging (DBSI)…

611 – DNA Methylation Clocks Are Altered in Persons With Undetectable HIV and Correlate With Brain Aging

Background DNA methylation (DNAm) clocks are quantitative markers of biological aging. The first-generation Horvath and Hannum clocks closely track actual age, second-generation clocks such as PhenoAge and GrimAge are sensitive to morbidity and mortality, and the third-generation DunedinPACE model estimates individual longitudinal “pace of aging.” Multiple studies have linked HIV infection with increased DNAm age;…

609 – A Transcriptional Signature of Induced Neurons Differentiates PWH on cART From People Without HIV

Background Neurocognitive impairment (NCI) is a prevalent and important co-morbidity in virologically suppressed people living with HIV (PWH), yet the underlying mechanisms remain elusive and effective treatments lacking. Given the limitations in models adequately replicating neuronal biology and injury in PWH, we explored the use of participant-derived directly induced neurons (iNs) for this purpose.  iNs have…